GTx Company Profile (NASDAQ:GTXI)

About GTx

GTx, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of small molecules for the treatment of cancer, including treatments for breast and prostate cancer, and other medical conditions. The Company is engaged in the development of selective androgen receptor modulators (SARMs). Its lead product candidate, enobosarm (GTx-024), had been evaluated in over 24 completed or ongoing clinical trials, including in approximately six Phase II and two Phase III clinical trials. The Company is also engaged in the development of GTx-758 (Capesaris), an oral nonsteroidal selective estrogen receptor alpha agonist, for secondary hormonal therapy in men with metastatic and high-risk non-metastatic castration resistant prostate cancer (CRPC). Its product candidate, Enobosarm, for the treatment of women with advanced androgen receptor (AR) positive triple-negative breast cancer (TNBC), is in Phase II clinical development-stage.

Industry, Sector and Symbol:

Sector: Medical
Industry: Biotechnology
Sub-Industry: Biotechnology
Exchange: NASDAQ
Symbol: GTXI
CUSIP: 40052B10

Key Metrics:

Previous Close: $0.77
50 Day Moving Average: $0.64
200 Day Moving Average: $0.63
52-Week Range: $141,915,000.00 - $0.29
Trailing P/E Ratio: 4.64
Foreward P/E Ratio: -6.42
P/E Growth: 0.00
Market Cap: $109.27M
Outstanding Shares: 141,915,000
Beta: 2.29

Profitability:

Return on Equity: 138.84%
Return on Assets: 56.58%

Debt:

Current Ratio: 6.18%
Quick Ratio: 6.18%

Additional Links:

Companies Related to GTx:

Consensus Ratings for GTx (NASDAQ:GTXI) (?)

Ratings Breakdown:	1 Hold Rating
Consensus Rating:	Hold (Score: 2.00)
Consensus Price Target:	$1.00 (29.87% upside)

Analysts' Ratings History for GTx (NASDAQ:GTXI)

Show:

Date	Firm	Action	Rating	Price Target	Details
9/9/2016	Jefferies Group	Reiterated Rating	Hold	$1.00

(Data available from 9/25/2014 forward)

Earnings History for GTx (NASDAQ:GTXI)

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Release Link	Conference Call
10/27/2016
8/9/2016	Q2	($0.05)	($0.04)		View	N/A
5/10/2016	Q1	($0.04)	$0.01		View	N/A
3/3/2016	Q415	($0.10)	($0.04)		View	Listen
10/29/2015	Q315	($0.06)	($0.04)		View	Listen
8/6/2015	Q215	($0.04)	($0.34)		View	Listen
5/8/2015	Q1	($0.04)	($0.04)		View	Listen
3/4/2015	Q314	($0.07)	($0.05)		View	Listen
11/10/2014	Q214	($0.11)	($0.06)		View	Listen
8/5/2014	Q2	($0.12)	($0.15)		View	N/A
5/8/2014	Q114	($0.12)	($0.14)		View	N/A
3/4/2014	Q413	($0.13)	($0.12)		View	Listen
11/12/2013	Q313	($0.21)	($0.14)		View	Listen
7/19/2013	Q2 2013	($0.22)	($0.20)		View	N/A
5/3/2013	Q1 2013	($0.21)	($0.20)		View	Listen
2/21/2013	Q4 2012	($0.21)	($0.17)		View	Listen
11/8/2012	Q312	($0.17)	$0.12	$1.93 million	View	N/A
8/8/2012		($0.17)	($0.17)		View	N/A
5/8/2012		($0.17)	($0.18)		View	N/A
2/21/2012		($0.17)	($0.17)		View	N/A
11/4/2011		($0.18)	($0.15)		View	N/A
8/9/2011		($0.19)	($0.21)		View	N/A
5/9/2011		($0.13)	($0.05)		View	N/A
2/24/2011		($0.16)	($0.16)		View	N/A

(Data available from 1/1/2011 forward)

Earnings Estimates for GTx (NASDAQ:GTXI)

Current Year EPS Consensus Estimate: $-0.12 EPS
Next Year EPS Consensus Estimate: $-0.12 EPS

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2016	1	($0.04)	($0.04)	($0.04)
Q2 2016	1	($0.05)	($0.05)	($0.05)
Q3 2016	1	($0.05)	($0.05)	($0.05)
Q4 2016	1	($0.03)	($0.03)	($0.03)

(Data provided by Zacks Investment Research)

Dividend History for GTx (NASDAQ:GTXI)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for GTx (NASDAQ:GTXI)

Insider Ownership Percentage: 40.60%
Institutional Ownership Percentage: 10.77%

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
6/16/2016	Robert James Wills	Chairman	Buy	100,000	$0.65	$65,000.00
3/1/2016	J Kenneth Glass	Director	Buy	44,000	$0.60	$26,400.00
1/26/2016	Marc Steven Hanover	CEO	Buy	4,000	$0.65	$2,600.00
1/25/2016	Marc Steven Hanover	CEO	Buy	12,813	$0.63	$8,072.19
1/19/2016	Marc Steven Hanover	CEO	Buy	25,000	$0.50	$12,500.00
1/14/2016	Marc Steven Hanover	CEO	Buy	25,000	$0.49	$12,250.00
12/24/2015	J Kenneth Glass	Director	Buy	100	$0.79	$79.00
12/22/2015	J Kenneth Glass	Director	Buy	1,907	$0.78	$1,487.46
12/21/2015	J Kenneth Glass	Director	Buy	39,900	$0.78	$31,122.00
5/19/2015	J Kenneth Glass	Director	Buy	24,500	$1.25	$30,625.00
5/14/2015	Robert James Wills	Chairman	Buy	46,140	$0.96	$44,294.40
5/8/2015	Henry Patton Doggrell	VP	Buy	25,477	$0.80	$20,381.60
5/8/2015	Robert James Wills	Chairman	Buy	50,000	$0.80	$40,000.00
4/22/2015	J Kenneth Glass	Director	Buy	10,000	$0.72	$7,200.00
4/21/2015	J Kenneth Glass	Director	Buy	11,608	$0.71	$8,241.68
4/15/2015	J Kenneth Glass	Director	Buy	3,300	$0.72	$2,376.00
4/10/2015	J Kenneth Glass	Director	Buy	16,400	$0.67	$10,988.00
9/23/2014	Marc Steven Hanover	CEO	Buy	5,000	$0.75	$3,750.00
9/17/2014	Marc Steven Hanover	CEO	Buy	10,000	$0.74	$7,400.00
8/21/2014	Marc Steven Hanover	CEO	Buy	20,000	$1.00	$20,000.00
8/19/2014	Marc Steven Hanover	CEO	Buy	10,000	$1.01	$10,100.00
8/8/2014	Henry Patton Doggrell	VP	Buy	10,000	$0.97	$9,700.00
8/8/2014	Marc Steven Hanover	CEO	Buy	30,000	$0.93	$27,900.00
8/7/2014	Jason T Shackelford	Insider	Buy	10,000	$0.92	$9,200.00
8/7/2014	Marc Steven Hanover	CEO	Buy	30,000	$0.92	$27,600.00
6/6/2014	James T Dalton	VP	Sell	72,883	$1.30	$94,747.90
3/21/2014	Jack Schuler	major shareholder	Sell	1,192,251	$1.84	$2,193,741.84
8/22/2013	Jack Schuler	major shareholder	Buy	93,777	$1.36	$127,536.72
8/21/2013	Jack Schuler	major shareholder	Buy	309,591	$1.42	$439,619.22
7/9/2013	Mark Edward Mosteller	CFO	Sell	17,000	$6.99	$118,830.00
1/17/2013	James T Dalton	VP	Sell	20,000	$5.20	$104,000.00
12/14/2012	Timothy R G Sear	Director	Buy	50,000	$4.33	$216,500.00
8/27/2012	J Kenneth Glass	Director	Buy	10,000	$3.76	$37,600.00

(Data available from 1/1/2013 forward)

Latest Headlines for GTx (NASDAQ:GTXI)

Date	Headline
	GTx, Inc. (GTXI) Completes Stage 1 Milestone in Phase 2 Trial of Enobosarm in ER+/AR+ Breast Cancer (NASDAQ:GTXI) www.streetinsider.com - September 8 at 5:15 PM
	GTX INC /DE/ Files SEC form 8-K, Other Events, Financial Statements and Exhibits (NASDAQ:GTXI) biz.yahoo.com - September 8 at 5:15 PM
	GTx Achieves Stage 1 Milestone in Phase 2 Clinical Trial of Enobosarm in ER+/AR+ Breast Cancer (NASDAQ:GTXI) finance.yahoo.com - September 8 at 9:12 AM
	7:02 am GTX achieves the Stage 1 milestone for the 9 mg cohort of its Phase 2 clinical trial of enobosarm to treat women with breast cancer; advances to stage 2 of trial (NASDAQ:GTXI) finance.yahoo.com - September 8 at 9:12 AM
	BIOSTAR Expands Range of VR Gaming Ready Products with GeForce GTX 1070 Graphics Card - More BIOSTAR graphics card options to experience Virtual Reality and Ultra High-Definition Games (NASDAQ:GTXI) www.publicnow.com - September 6 at 10:05 AM
	GTx Announces Webcast of Corporate Presentation at Baird’s 2016 Healthcare Conference (NASDAQ:GTXI) finance.yahoo.com - September 2 at 10:10 AM
	BRIEF-GTX Inc says size of board increased to seven directors from six - SEC filing (NASDAQ:GTXI) www.reuters.com - September 1 at 5:12 PM
	GTx, Inc. Appoints To Board Of Directors (NASDAQ:GTXI) www.biospace.com - September 1 at 5:12 PM
	GTx Appoints Dr. Garry Neil to Board of Directors (NASDAQ:GTXI) www.publicnow.com - September 1 at 8:15 AM
	GTX INC /DE/ Files SEC form 8-K, Change in Directors or Principal Officers (NASDAQ:GTXI) biz.yahoo.com - September 1 at 8:15 AM
	GIGABYTE Releases GeForce® GTX 1060 XTREME GAMING 6GB Graphics Card (NASDAQ:GTXI) www.publicnow.com - August 23 at 9:44 AM
	GTX INC /DE/ Financials (NASDAQ:GTXI) finance.yahoo.com - August 19 at 5:17 PM
	GIGABYTE Releases GeForce® GTX 1060 Graphics Cards Equipped with 3GB Memory (NASDAQ:GTXI) www.publicnow.com - August 18 at 5:22 PM
	GIGABYTE Introduces the GeForce® GTX 10 Series Gaming Laptops (NASDAQ:GTXI) www.publicnow.com - August 16 at 8:43 AM
	Nvidia: 'GTX1080′ Will Power Them to Blow Away Q2 Estimate, Says M Science (NASDAQ:GTXI) blogs.barrons.com - August 11 at 5:34 PM
	Memphis-based GTx posts $6 million loss (NASDAQ:GTXI) www.commercialappeal.com - August 10 at 12:47 PM
	GTx, Inc. Provides Corporate Update And Reports Second Quarter 2016 Financial Results (NASDAQ:GTXI) www.biospace.com - August 10 at 12:47 PM
	GTx Provides Corporate Update and Reports Second Quarter 2016 Financial Results (NASDAQ:GTXI) www.tmcnet.com - August 9 at 8:18 AM
	GTx reports 2Q loss (NASDAQ:GTXI) www.cnbc.com - August 9 at 8:18 AM
	GTx Inc.: GTx Provides Corporate Update and Reports Second Quarter 2016 Financial Results (NASDAQ:GTXI) www.twst.com - August 9 at 8:18 AM
	GTx beats by $0.01 (NASDAQ:GTXI) seekingalpha.com - August 9 at 7:16 AM
	GIGABYTE to Release GeForce® GTX 1060 G1 GAMING Graphics Card (NASDAQ:GTXI) www.publicnow.com - July 7 at 9:31 AM
	GIGABYTE Adds Two New Models to GeForce® GTX 1070 Line (NASDAQ:GTXI) www.publicnow.com - July 7 at 2:21 AM
	GIGABYTE Releases GeForce® GTX 1070 XTREME GAMING Graphics Card (NASDAQ:GTXI) www.publicnow.com - July 1 at 10:21 AM
	GTX INC /DE/ : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K) (NASDAQ:GTXI) www.4-traders.com - June 22 at 5:27 PM
	GTX INC /DE/ Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Tran (NASDAQ:GTXI) biz.yahoo.com - June 22 at 10:01 AM
	GTx, Inc Therapeutics Drugs and Companies Pipeline Review H1 2016 Research Report (NASDAQ:GTXI) www.medgadget.com - June 22 at 9:59 AM
	GTx (GTXI) Shows Strength: Stock Adds 11.2% in Session (NASDAQ:GTXI) finance.yahoo.com - June 21 at 8:15 AM
	Form 4 GTX INC /DE/ For: Jun 16 Filed by: Wills Robert James (NASDAQ:GTXI) www.streetinsider.com - June 20 at 11:34 AM
	GIGABYTE Releases GeForce® GTX 1070 G1 GAMING Graphics Card (NASDAQ:GTXI) www.publicnow.com - June 17 at 2:29 AM
	GTx, Inc. :GTXI-US: Earnings Analysis: Q1, 2016 By the Numbers : June 8, 2016 (NASDAQ:GTXI) www.capitalcube.com - June 8 at 6:07 PM
	GIGABYTE Launches GeForce® GTX 1080 XTREME GAMING Graphics Card (NASDAQ:GTXI) www.publicnow.com - June 7 at 10:28 AM
	GTx, Inc. Pipeline Review, Industry Analysis, Market Size and Forecast 2016 to 2020 (NASDAQ:GTXI) www.medgadget.com - June 2 at 11:30 PM
	GTx Announces Webcast of Corporate Presentation at Jefferies 2016 Global Healthcare Conference (NASDAQ:GTXI) www.publicnow.com - June 2 at 7:15 AM
	Critics Call GeForce GTX 1070 “One Hell of a Graphics Card,” “Major Value,” “Significant Leap” (NASDAQ:GTXI) www.publicnow.com - May 31 at 10:52 AM
	Gtx Incorporated (NASDAQ:GTXI) Sellers Covered 15.99% of Their Shorts - HNN (NASDAQ:GTXI) hintsnewsnetwork.com - May 29 at 2:20 PM
	Today's Watch List: Curis, Inc. (NASDAQ:CRIS), Innocoll Holdings plc (NASDAQ:INNL), Guidewire Software, Inc ... - KC Register (NASDAQ:GTXI) www.kcregister.com - May 27 at 2:53 PM
	GTx, Inc. (NASDAQ:GTXI) Quarterly EPS From Continuing Operations Stands At $0.0149 - Investor Newswire (NASDAQ:GTXI) www.investornewswire.com - May 24 at 2:43 PM
	GTx Announces Webcast of Corporate Presentation at the UBS Global Healthcare Conference 2016 (NASDAQ:GTXI) finance.yahoo.com - May 16 at 7:00 AM
	GTx Inc.: GTx Provides Corporate Update and Reports First Quarter 2016 Financial Results (NASDAQ:GTXI) www.twst.com - May 11 at 8:03 AM
	GTx Provides Corporate Update and Reports First Quarter 2016 Financial Results (NASDAQ:GTXI) www.publicnow.com - May 10 at 7:18 AM
	GTx posts 1Q profit (NASDAQ:GTXI) sg.finance.yahoo.com - May 10 at 7:14 AM
	Q1 2016 GTX Inc Earnings Release - Before Market Open (NASDAQ:GTXI) biz.yahoo.com - May 10 at 7:07 AM
	GTx Announces Presentation of Preclinical Data Demonstrating the Ability of SARDs to Degrade and Inhibit the Androgen Receptor at the American Urological Association Annual Meeting (NASDAQ:GTXI) finance.yahoo.com - May 9 at 7:00 AM
	NVIDIA CEO Jen-Hsun Huang Unveils GeForce GTX 1080, World’s Most Advanced GPU (NASDAQ:GTXI) www.publicnow.com - May 6 at 11:06 PM
	GTx, Inc. to Report First Quarter 2016 Financial Results on May 10, 2016 (NASDAQ:GTXI) www.publicnow.com - April 27 at 7:21 AM
	GTx (GTXI) Worth a Look: Stock Moves 6.9% Higher (NASDAQ:GTXI) www.zacks.com - April 20 at 9:56 AM
	Nikkei rallies to 1-1/2 week high on weaker yen, China trade data (NASDAQ:GTXI) feeds.reuters.com - April 13 at 3:17 AM
	New Market Research Report: Cancer Cachexia Global Clinical Trials Review, H1, 2016 (NASDAQ:GTXI) www.sbwire.com - April 7 at 12:59 PM
	Edited Transcript of GTXI earnings conference call or presentation 3-Mar-16 2:00pm GMT (NASDAQ:GTXI) finance.yahoo.com - April 6 at 5:24 PM